Compare GLAD & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLAD | CLPT |
|---|---|---|
| Founded | 2001 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.6M | 467.9M |
| IPO Year | 2001 | 2009 |
| Metric | GLAD | CLPT |
|---|---|---|
| Price | $18.61 | $10.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $22.00 | ★ $23.50 |
| AVG Volume (30 Days) | 167.1K | ★ 598.7K |
| Earning Date | 11-17-2026 | 10-28-2026 |
| Dividend Yield | ★ 9.60% | N/A |
| EPS Growth | ★ 91.82 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $12.97 | $32.54 |
| Revenue Next Year | $9.43 | $15.41 |
| P/E Ratio | $18.72 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $16.54 | $8.27 |
| 52 Week High | $21.73 | $24.73 |
| Indicator | GLAD | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 49.08 |
| Support Level | $18.39 | $8.61 |
| Resistance Level | $19.59 | $11.90 |
| Average True Range (ATR) | 0.37 | 0.50 |
| MACD | -0.00 | 0.20 |
| Stochastic Oscillator | 43.53 | 97.28 |
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.